In August 2022, the below number of individuals have been recruited in Swedegene. DNA and clinical data collection for these are completed.

ADR type	Number
Angioedema	542
Anaphylaxis	137
Urticaria	204
Other allergic reactions	120
Cough related to ACE-inhibitors	150
Osteonecrosis and atypical fractures due to bisphosphonates	138
Phototoxic reactions (mainly due to topical NSAIDs)	51
Blood cell dyscrasia (agranulocytosis, thrombocytopenia and anemia) to non-cytostatic drugs	299
Metabolic reactions from neuroleptics and antidepressants (mainly weight gain)	72
Hyponatremia/SIADH due to antidepressants and antiepileptics	39
CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics	95
Stevens-Johnson syndrome/Toxic epidermal necrolysis	66
Tendon-rupture from flouroquinolones	31
Liver toxicity	462
Rhabdomyolysis related to statins/fibrates	54
Torsade de Pointes/QT-prolongation	26
Narcolepsy associated with Pandemrix	83
Hypersomnia associated with Pandemrix	12
Pancreatitis	96
Alopecia	28
Bleedings from new oral anticoagulants (NOACs)	141
Lack of efficacy of NOACs	32
Pneumonitis	28
Renal toxicity	89
Ankle oedema from calcium channel blockers	17
Gingival hyperplasia from calcium channel blockers	8
Adverse reactions to Covid-19 vaccines	412
Controls	580
Total number of cases	3835

ACE = angiotensin converting enzyme; NSAID = non-steroidal anti-inflammatory drug; NOAC=non-vitamin K oral anticoagulant drug.

Note that the number of cases for a particular ADR may be greater than the total number of cases as some individuals have experienced multiple ADRs concomitantly.